SELLAS Life Sciences Group, Inc. SLS
NASDAQ · United States · Health Technology
$11.33-0.98 (-7.96%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.05 | -0.05 | -11.1% | +6.6%$11.04→$11.77 |
| Q4 2025 | 2026-03-19 | -0.05 | -0.06 | +16.7% | -3.8%$4.95→$4.76 |
| Q3 2025 | 2025-11-12 | -0.06 | -0.08 | +25.0% | -3.3%$1.51→$1.46 |
| Q2 2025 | 2025-08-12 | -0.07 | -0.08 | +12.5% | — |
| Q1 2025 | 2025-05-13 | -0.07 | -0.11 | +36.4% | — |
| Q4 2024 | 2025-03-20 | -0.08 | -0.11 | +27.3% | — |
| Q3 2024 | 2024-11-13 | -0.10 | -0.13 | +23.1% | — |
| Q2 2024 | 2024-08-13 | -0.13 | -0.17 | +23.5% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.